Bibliometrics of scientific biomedical publications on Primary Immunodeficiency Diseases in the Arab World (2020-2024)

##plugins.themes.academic_pro.article.sidebar##

Cartographie d’affiliation des 119 auteurs du Monde Arabe, ayant cosigné chacun au minimum deux publications biomédicales scientifiques spécifiques aux «Primary Immunodeficiency Diseases», entre 2020-2024 (MEDLINE).
Published Aug 1, 2025
https://doi.org/10.62438/tunismed.v103i8.6080
Download
pdf
Vol. 103 No. 8 (2025): Tunis Med Aug 2025

##plugins.themes.academic_pro.article.main##

Asma Ben Abdelaziz
Regional Health Directorate of Sousse, Sahloul Hospital of Sousse. Faculty of Pharmacy of Monastir. University of Sousse, Tunisia
Youssef Zanina
Research Laboratory LR 19 SP 01 "Measurement and Support for Hospital Performance", Tunisia
Salima Bradai
Regional Health Directorate of Sousse, Sahloul Hospital, Sousse. Research Laboratory LR 19 SP 01 ‘Hospital Performance Measurement and Support’, Tunisia
Najeh Adaly
Regional Health Directorate of Sousse, Sahloul Hospital of Sousse. Faculty of Medicine ‘Ibn Al Jazzar’. University of Sousse, Tunisia
Mohamed Khelil
Regional Health Directorate of Sousse, Sahloul Hospital in Sousse. Research Laboratory LR 19 SP 01 ‘Measurement and Support for Hospital Performance’, Tunisia
Ahmed Ben Abdelaziz
Regional Health Directorate of Sousse, Sahloul Hospital of Sousse. Research Laboratory LR 19 SP 01 ‘Measurement and Support for Hospital Performance’, Faculty of Medicine ‘Ibn Al Jazzar’. University of Sousse, Tunisia

Abstract

Objective: Describing the editorial, methodological and thematic profile of scientific publications on Primary Immunodeficiency Diseases in the Arab World during the five-year period 2020-2024.


Methods: Based on the MeSH descriptor ‘Primary Immunodeficiency Diseases’ (PID), combined with the names of 22 Arab countries, this bibliometric study was conducted on MEDLINE, via Web of Science, analyzing all available bibliographic fields. The number of authors was limited to researchers from the Arab world who had co-authored at least two publications during the study period. Visualization of author and research topic clusters was carried out using VOS Viewer.


Results: During the five-year study period, 156 publications from the Arab world were indexed under the PID descriptor, published by 86 scientific journals, and tagged with 479 MeSH descriptors. These publications, often of the ‘Case Reports’ (19%) and ‘Review Article’ (15%) type, were mainly categorized under ‘Immunology’ (62%), “Pediatrics” (47%) and ‘Genetics’ (39%). They were published particularly by the Journal of Clinical Immunology (15%) and Frontiers in Immunology (12%). Among the 119 co-authors of these publications, from 12 countries, the most prolific were AL-HERZ (Kuwait), BOUSFIHA (Morocco) and ADELI (Qatar). These studies were often retrospective in nature, focused on children and the problem of “Severe Combined Immunodeficiency”, particularly in Egypt, Saudi Arabia, Oman and Morocco. In addition to the ‘Genetics’ approach (39%), notably ‘Genetic Predisposition To Disease’ and ‘Genetic Diseases Inborn’, these publications also addressed “Immunology” (19%), including topics such as ‘Immunologic Deficiency Syndromes’ and ‘Acquired Immunodeficiency Syndrome’...(abstract truncated at 250 wordsà.

Keywords:

Primary Immunodeficiency Diseases , Genetic Diseases, Inborn - Immunologic Deficiency Syndromes , Bibliometrics , MEDLINE , Arab World.

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Bousfiha AA, Jeddane L, Moundir A, Poli MC, Aksentijevich I, Cunningham-Rundles C, et al. The 2024 update of IUIS phenotypic classification of human inborn errors of immunity. J Hum Immun. 2025;1(1).
  2. Fasseeh AN, Korra N, Aljedai A, Seyam A, Almudaiheem H, Al-Abdulkarim HA, et al. Rare disease challenges and potential actions in the Middle East. Int J Equity Health. 2025;24(1):56.
  3. Anderson JT, Cowan J, Condino-Neto A, Levy D, Prusty S. Health-related quality of life in primary immunodeficiencies: Impact of delayed diagnosis and treatment burden. Clin Immunol. 2022;236:108931.
  4. Villavicencio MF, Pedroza LA. Diagnosis of primary immunodeficiency diseases in the developing world: the need for education and networking with the developed world. Curr Opin Pediatr. 2019;31(6):835-42.
  5. El Goundali K, Chebabe M, Zahra Laamiri F, Hilali A. The Determinants of Consanguineous Marriages among the Arab Population: A Systematic Review. Iran J Public Health. 2022;51(2):253-65.
  6. Bousfiha AA, Errami A, Jeddane L, Mellouli F, Reda SM, Adeli M, et al. Primary Immunodeficiencies: Epidemiology in the Maghreb. Tunis Med. 2018;96(10-11):672-7.
  7. Al-Mousa H, Al-Saud B. Primary Immunodeficiency Diseases in Highly Consanguineous Populations from Middle East and North Africa: Epidemiology, Diagnosis, and Care. Front Immunol. 2017;8:678.
  8. Al-Herz W, Ziyab AH, Adeli M, Al Farsi T, Al-Hammadi S, Al Kuwaiti AA, et al. Epidemiology of combined immunodeficiencies affecting cellular and humoral immunity- a multicentric retrospective cohort study from the Arabian Peninsula. Clin Immunol. 2023;254:109696.
  9. Baris S, Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S, et al. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity. J Allergy Clin Immunol Pract. 2023;11(1):158-80.e11.
  10. Meyts I, Bousfiha A, Duff C, Singh S, Lau YL, Condino-Neto A, et al. Primary Immunodeficiencies: A Decade of Progress and a Promising Future. Front Immunol. 2020;11:625753.
  11. Tadmouri GO, Mandil A, Rashidian A. Biomedical and health research geography in the Eastern Mediterranean Region. East Mediterr Health J. 2019;25(10):728-43.
  12. U.S. National Library of Medicine. MEDLINE 2025 [mise à jour 05/02/2024; consulté le 20/04/2025]. Disponible: https://www.nlm.nih.gov/medline/
  13. U.S. National Library of Medicine. Primary Immunodeficiency Diseases [MeSH Term]. 2019 [mise à jour 08/07/2019; consulté le 20/04/2025]. Disponible: https://www.ncbi.nlm.nih.gov/mesh/?term=Primary+Immunodeficiency+Diseases
  14. Web of science. Web of Science Core Collection: Clarivate; 2025 [mise à jour 20/04/2025; consulté le 20/04/2025]. Disponible: https://www.webofscience.com/
  15. DonnéesMondiales.com. Les pays membres de la Ligue arabe 2025 [mise à jour février 2022; consulté le 20/04/2025]. Disponible: https://www.donneesmondiales.com/alliances/ligue-arabe.php
  16. Al-Mousa H, Barbouche MR. Genetics of Inborn Errors of Immunity in highly consanguineous Middle Eastern and North African populations. Semin Immunol. 2023;67:101763.
  17. Gasparyan AY. Bibliographic databases: some critical points. J Korean Med Sci. 2013;28(6):799-800.
  18. The World Bank. Arab World | Data. The World Bank; 2025.
  19. Stoller JK. The Challenge of Rare Diseases. Chest. 2018;153(6):1309-14.
  20. Yazdanpanah N, Rezaei N. The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations. Expert Rev Clin Immunol. 2024;20(10):1237-59.
  21. Moundir A, Ouair H, Benhsaien I, Jeddane L, Rada N, Amenzoui N, et al. Genetic Diagnosis of Inborn Errors of Immunity in an Emerging Country: a Retrospective Study of 216 Moroccan Patients. J Clin Immunol. 2023;43(2):485-94.
  22. Ochs HD, Petroni D. From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disorders. Am J Med Genet A. 2018;176(4):784-803.
  23. Boldt A, Bitar M, Sack U. Flow Cytometric Evaluation of Primary Immunodeficiencies. Clin Lab Med. 2017;37(4):895-913.
  24. Erman B, Çipe F. Genetic Screening of the Patients with Primary Immunodeficiency by Whole-Exome Sequencing. Pediatr Allergy Immunol Pulmonol. 2020;33(1):19-24.
  25. Valencic E, Smid A, Jakopin Z, Tommasini A, Mlinaric-Rascan I. Repositioning Drugs for Rare Immune Diseases: Hopes and Challenges for a Precision Medicine. Curr Med Chem. 2018;25(24):2764-82.
  26. White MJ, Nazareth-Pidgeon K, Key-Solle M, Nerlinger A, Parente V. Creation to Dissemination: A Roadmap for Health Equity Research. Hosp Pediatr. 2024;14(10):e461-e6.
  27. Ravid K, Faux R, Corkey B, Coleman D. Building interdisciplinary biomedical research using novel collaboratives. Acad Med. 2013;88(2):179-84.
  28. Madhu A, Cherian I, Gautam AK. Chapter 16 - Interdisciplinary approach to biomedical research: a panacea to efficient research output during the global pandemic. In: Egbuna C, editor. Coronavirus Drug Discovery. 1. Amsterdam (NL): Elsevier; 2022. p. 331-47.
  29. Rahman NA, Rajaratnam V, Burchell GL, Morgan K, Abdullah MR, Zweekhorst MBM, et al. The transdisciplinary research process and participatory research approaches used in the field of neglected tropical diseases: A scoping review. PLoS Negl Trop Dis. 2025;19(4):e0012959.
  30. Ly YT, Arndt F, Boschert AL, Pavletić B, Webner F, Kohl A, et al. [After the pandemic is before the pandemic: And how interdisciplinary research can help here]. Laryngorhinootologie. 2024;103(8):570-7.
  31. Patel K, Ündar A. Impact of a Multidisciplinary Research Team Approach to Prevent Avoidable Mistakes for Neonatal CPB Population. World J Pediatr Congenit Heart Surg. 2022;13(2):220-30.
  32. Torres MJ, Agundez J, Barber D, Bartra J, Davila I, Escribese MM, et al. ARADyAL: The Spanish Multidisciplinary Research Network for Allergic Diseases. J Investig Allergol Clin Immunol. 2021;31(2):108-19.
  33. Abozaid GM, Kerr K, McKnight A, Al-Omar HA. Criteria to define rare diseases and orphan drugs: a systematic review protocol. BMJ Open. 2022;12(7):e062126.
  34. Ben Abdelaziz A, Ben Abdelaziz A, Zanina Y, Bradai S, Alaya N, Khelil M. A review of the medical literature on Primary Immunodeficiency Diseases in the Arab World: Towards a roadmap to 2030. Moroc Health J. 2025;41:45-51.
  35. Salcido R. Patient Registries: Requirements and Revenues. Adv Skin Wound Care. 2015;28(7):296.
  36. Abolhassani H, Azizi G, Sharifi L, Yazdani R, Mohsenzadegan M, Delavari S, et al. Global systematic review of primary immunodeficiency registries. Expert Rev Clin Immunol. 2020;16(7):717-32.
  37. El-Sayed ZA, Radwan N. Newborn Screening for Primary Immunodeficiencies: The Gaps, Challenges, and Outlook for Developing Countries. Front Immunol. 2019;10:2987.
  38. Aghamohammadi A, Rezaei N, Yazdani R, Delavari S, Kutukculer N, Topyildiz E, et al. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity. J Clin Immunol. 2021;41(6):1339-51.
  39. Yagoubi A, Tahiat A, Touri NS, Ladj MS, Drali O, Belaid B, et al. Algerian Registry for Inborn Errors of Immunity in Children: Report of 887 Children (1985-2021). J Clin Immunol. 2022;42(8):1660-71.
  40. Al-Herz W, Al-Ahmad M, Al-Khabaz A, Husain A, Sadek A, Othman Y. The Kuwait National Primary Immunodeficiency Registry 2004-2018. Front Immunol. 2019;10:1754.
  41. Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, et al. Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988-2012). J Clin Immunol. 2015;35(8):745-53.
  42. Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012). J Clin Immunol. 2014;34(4):459-68.
  43. Aranda CS, Gouveia-Pereira MP, da Silva CJM, Rizzo M, Ishizuka E, de Oliveira EB, et al. Severe combined immunodeficiency diagnosis and genetic defects. Immunol Rev. 2024;322(1):138-47.
  44. Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA. Consanguinity and reproductive health among Arabs. Reprod Health. 2009;6:17.
  45. Institut P. Amélioration de la prise en charge des Déficits Immunitaires Primitifs de l’enfant et de l’adulte dans les régions défavorisées du nord-ouest de la Tunisie. Institut Pasteur - Research2025.
  46. Kohn LA, Kohn DB. Gene Therapies for Primary Immune Deficiencies. Front Immunol. 2021;12:648951.
  47. Koniali L, Lederer CW, Kleanthous M. Therapy Development by Genome Editing of Hematopoietic Stem Cells. Cells. 2021;10(6).